Edwards Lifesciences Corporation (EW)
NYSE: EW · Real-Time Price · USD
86.53
+0.87 (1.02%)
At close: Dec 22, 2025, 4:00 PM EST
85.60
-0.93 (-1.07%)
After-hours: Dec 22, 2025, 7:47 PM EST
Edwards Lifesciences Revenue
Edwards Lifesciences had revenue of $1.55B in the quarter ending September 30, 2025, with 14.67% growth. This brings the company's revenue in the last twelve months to $5.88B, up 10.60% year-over-year. In the year 2024, Edwards Lifesciences had annual revenue of $5.44B with 8.57% growth.
Revenue (ttm)
$5.88B
Revenue Growth
+10.60%
P/S Ratio
8.63
Revenue / Employee
$372,392
Employees
15,800
Market Cap
50.21B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 5.44B | 429.50M | 8.57% |
| Dec 31, 2023 | 5.01B | 546.00M | 12.23% |
| Dec 31, 2022 | 4.46B | -768.50M | -14.69% |
| Dec 31, 2021 | 5.23B | 846.20M | 19.29% |
| Dec 31, 2020 | 4.39B | 38.30M | 0.88% |
| Dec 31, 2019 | 4.35B | 625.20M | 16.79% |
| Dec 31, 2018 | 3.72B | 287.50M | 8.37% |
| Dec 31, 2017 | 3.44B | 471.60M | 15.91% |
| Dec 31, 2016 | 2.96B | 470.00M | 18.85% |
| Dec 31, 2015 | 2.49B | 170.80M | 7.35% |
| Dec 31, 2014 | 2.32B | 277.40M | 13.56% |
| Dec 31, 2013 | 2.05B | 145.90M | 7.68% |
| Dec 31, 2012 | 1.90B | 221.00M | 13.17% |
| Dec 31, 2011 | 1.68B | 231.60M | 16.01% |
| Dec 31, 2010 | 1.45B | 125.60M | 9.51% |
| Dec 31, 2009 | 1.32B | 83.70M | 6.76% |
| Dec 31, 2008 | 1.24B | 146.60M | 13.44% |
| Dec 31, 2007 | 1.09B | 54.10M | 5.22% |
| Dec 31, 2006 | 1.04B | 39.10M | 3.92% |
| Dec 31, 2005 | 997.90M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
EW News
- 4 days ago - Edwards Lifesciences to Present at the 44th Annual J.P. Morgan Healthcare Conference - Business Wire
- 11 days ago - Edwards Lifesciences Corporation (EW) Analyst/Investor Day Transcript - Seeking Alpha
- 18 days ago - Edwards Lifesciences Reaffirms Strategy for Sustainable, Differentiated Growth at Annual Investor Conference - Business Wire
- 22 days ago - HALPER SADEH LLC ENCOURAGES EDWARDS LIFESCIENCES CORPORATION SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS - PRNewsWire
- 4 weeks ago - Artisan Global Discovery Fund: Q3 Delivers Strong Results Amid Trimming And Exits - Seeking Alpha
- 6 weeks ago - Edwards Champions American Heart Association Initiative to Reduce Deaths, Improve Care for Patients With Heart Valve Disease - Business Wire
- 7 weeks ago - Edwards Lifesciences Corporation (EW) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 7 weeks ago - Edwards Lifesciences beats quarterly estimates on strength in heart devices - Reuters